Domain-Specific Agonist Binding Affinities Explain Structural and Functional Regulation of TRPM2

This study establishes that the high-affinity binding of ADP-ribose to the MHR1/2 domain, rather than the low-affinity NUDT9H domain, is the primary driver of TRPM2 channel activation under physiological conditions, suggesting the latter primarily serves a structural role.

The Gist

Imagine your body as a bustling city. Inside this city, there are tiny security guards called TRPM2 channels. These guards sit on the walls of your cells, acting as gates that control the flow of calcium (a vital signal for the cell).

Usually, these gates are locked. But when the city faces an attack—like an invasion of "oxidative stress" (think of it as a chemical fire or pollution)—the guards need to open the gates to sound the alarm and call for help.

For a long time, scientists were confused about how these guards know when to open. They knew a chemical messenger called ADPR (a tiny key) was involved, but the guard had two different locks on it:

1. Lock A (The MHR1/2 domain): Located at the front of the guard.
2. Lock B (The NUDT9H domain): Located at the back, near the guard's "tail."

The big mystery was: Which lock does the key actually turn to open the gate? Does it need to turn both? Or just one?

The Great Key Experiment

In this study, the scientists decided to test the locks individually, like taking the front and back of a car door off to see which one actually holds the latch.

1. The "Velcro" vs. The "Slippery Slide"
They measured how tightly the key (ADPR) stuck to each lock.

• Lock A (MHR1/2): This lock grabbed the key like super-strong Velcro. It held on incredibly tight, even when there were very few keys around.
• Lock B (NUDT9H): This lock was like a slippery slide. The key barely stuck to it at all. You would need a mountain of keys just to get one to stay on long enough to do anything.

The Result: The front lock (MHR1/2) is the real deal. It's the one that actually grabs the key to start the process. The back lock (NUDT9H) is so weak that under normal city conditions, it's practically useless for opening the gate.

2. The "Fake Key" Problem
The scientists also tried a special "super-key" called 8-Br-cADPR. Previous studies suggested this key only fit in the front lock. However, in their experiments, it seemed to stick to the back lock too.

• The Twist: They discovered that the "super-key" was unstable. Under the heat of the experiment, it was breaking apart into a regular key (ADPR) that could stick to the back lock. It wasn't the back lock working; it was a chemical accident!

3. The "Broken Gear" Test
To be sure, they broke specific parts of the locks (using mutations) to see what happened.

• When they broke the Front Lock, the gate wouldn't open at all. The guard was useless.
• When they broke the Back Lock, the gate still opened just fine!
• Conclusion: The back lock isn't the switch. It's more like a structural beam or a safety rail. It helps hold the guard together and keeps the shape right, but it doesn't actually pull the trigger to open the gate.

The Real-World Check: How Many Keys Are There?

Finally, the scientists asked: "In a real cell, how many keys are floating around?"

• They measured the amount of ADPR in cells before and after stress.
• The Finding: Even during a chemical fire (stress), the number of keys in the cell is enough to saturate the Front Lock (Velcro) but is far too low to ever fill up the Back Lock (Slippery Slide).

The Big Picture Analogy

Think of the TRPM2 channel as a smart door with two sensors:

• Sensor 1 (Front): A highly sensitive motion detector. Even a single person walking by (a tiny amount of ADPR) triggers the door to unlock.
• Sensor 2 (Back): A heavy-duty, low-sensitivity pressure plate. It requires a truck to drive over it to trigger.

The scientists found that in real life, we never have enough "trucks" (ADPR) to trigger the pressure plate. The door opens because the motion detector (Front Lock) is so sensitive. The pressure plate (Back Lock) is still there, but it's mostly just there to make sure the door frame doesn't collapse.

Why Does This Matter?

This discovery changes how we understand how our cells react to stress and inflammation.

• Old Idea: We thought the cell needed a massive flood of chemicals to open these gates.
• New Idea: The gates are actually very sensitive. They open with just a whisper of a signal because of that high-affinity front lock.

This is huge news for medicine. If we want to design drugs to stop these gates from opening (to treat diseases like stroke, diabetes, or neurodegeneration), we shouldn't waste time trying to jam the back lock. We need to focus on the front lock, because that's the one actually doing the work.

In short: The TRPM2 channel has a "master key" slot that is super sensitive, and a "decoration" slot that is mostly structural. The cell uses the sensitive slot to react to danger, while the decoration slot just helps keep the door standing up.

Technical Summary

1. Problem Statement

The Transient Receptor Potential Melastatin 2 (TRPM2) channel is a critical Ca²⁺-permeable cation channel activated by oxidative stress and the nucleotide ADP-ribose (ADPR). It plays a pivotal role in immune activation, inflammation, and cell death, making it a target for treating conditions like stroke, diabetes, and neurodegeneration.

Despite extensive structural studies (cryo-EM), the functional interplay between TRPM2's two nucleotide-binding domains remains unclear:

• MHR1/2: Located in the N-terminal TRPM homology region.
• NUDT9H: Located in the C-terminus, homologous to the mitochondrial ADPR-pyrophosphatase NUDT9.

Previous studies yielded conflicting data regarding the binding affinities ($K_d$) of these domains for ADPR and its analogs (e.g., dADPR, 8-Br-cADPR). Some studies suggested the NUDT9H domain is the primary activation site, while others pointed to MHR1/2. Furthermore, the physiological relevance of these affinities relative to intracellular ADPR concentrations during oxidative stress was unknown. The lack of quantitative, domain-specific affinity data hindered the development of a coherent model for TRPM2 gating.

2. Methodology

The authors employed a multi-disciplinary approach combining biophysics, mutagenesis, electrophysiology, and metabolomics:

• Protein Expression & Purification: Isolated human TRPM2 domains (MHR1/2 and NUDT9H) were expressed in Expi293 cells and E. coli, respectively, and purified to homogeneity.
• Biophysical Binding Assays:
  • Nano-Differential Scanning Fluorimetry (nDSF): Used to measure thermal stability shifts ($T_m$) upon ligand binding to determine dissociation constants ($K_d$) for ADPR, 2'-deoxy-ADPR (dADPR), and 8-Br-cADPR.
  • Isothermal Titration Calorimetry (ITC): Used to validate NUDT9H binding affinities.
  • HPLC Analysis: Performed to assess the chemical stability of 8-Br-cADPR under experimental conditions.
• Site-Directed Mutagenesis: Eight alanine mutants were generated in key residues (M215, Y295, R302, R358 in MHR1/2; R1433, Y1485, N1487 in NUDT9H) to probe the functional importance of specific binding pocket residues.
• Electrophysiology: Whole-cell patch-clamp recordings in HEK293 cells expressing wild-type and mutant TRPM2 channels to correlate binding affinity changes with channel gating (current activation).
• Cellular Quantification:
  • Metabolomics (LC-MS/MS): Measured absolute intracellular ADPR concentrations in resting and H₂O₂-stimulated HEK293T cells.
  • Fluorescent Biosensor: Utilized a genetically encoded ADPR biosensor (based on Shewanella oneidensis NrtR) for real-time, ratiometric monitoring of intracellular ADPR dynamics.

3. Key Results

A. Differential Binding Affinities

• MHR1/2 Domain: Exhibits high affinity for ADPR ($K_d \approx 0.51 \, \mu\text{M}$) and dADPR ($K_d \approx 0.21 \, \mu\text{M}$).
• NUDT9H Domain: Exhibits low affinity, approximately three orders of magnitude weaker than MHR1/2.
  • ADPR $K_d \approx 192 \, \mu\text{M}$ (confirmed by both nDSF and ITC).
  • dADPR $K_d \approx 124 \, \mu\text{M}$.
• Ligand Specificity: There was no significant difference in affinity between ADPR and dADPR for either domain, suggesting dADPR's "superagonist" status (faster activation) is due to gating kinetics rather than binding affinity.

B. Stability of 8-Br-cADPR

The study revealed that 8-Br-cADPR is chemically unstable under nDSF conditions (elevated temperature + TCEP reducing agent). It rapidly degrades into linear 8-Br-ADPR, cADPR, and ADPR. This explains previous discrepancies where 8-Br-cADPR appeared to bind NUDT9H; the observed binding was likely due to the degradation product 8-Br-ADPR.

C. Mutational Analysis

• MHR1/2 Mutants: Mutations M215A and Y295A significantly reduced ligand affinity and abolished channel currents, confirming MHR1/2 is essential for activation.
• NUDT9H Mutants: Mutations like R1433A drastically reduced NUDT9H affinity (e.g., dADPR $K_d$ increased >20-fold), yet these mutations had modest or negligible effects on channel activation in electrophysiology assays. This suggests that while NUDT9H binds ligands, this binding is not the primary driver of gating.

D. Physiological ADPR Concentrations

• Resting Cells: Basal free ADPR concentration was measured at ~1.0 µM (biosensor) and 0.39 µM (metabolomics).
• Stimulated Cells: Upon H₂O₂ stimulation, total cellular ADPR rose to a maximum of ~10 µM.
• Comparison: These physiological concentrations (1–10 µM) are sufficient to saturate the high-affinity MHR1/2 domain but are far below the $K_d$ required to significantly occupy the low-affinity NUDT9H domain (~192 µM).

4. Key Contributions & Significance

1. Resolution of the Activation Mechanism: The study provides a quantitative framework establishing that high-affinity binding to the MHR1/2 domain is sufficient to drive TRPM2 activation under physiological and oxidative stress conditions.
2. Re-evaluation of NUDT9H Function: The authors propose a paradigm shift: the NUDT9H domain likely serves a structural role, maintaining the integrity of the channel's gating ring, rather than acting as the primary ligand-sensing switch for activation. Its low affinity makes it unlikely to be occupied at physiological ADPR levels.
3. Clarification of Ligand Specificity: The work explains why 8-Br-cADPR acts as an antagonist (binding MHR1/2) and clarifies the instability of brominated nucleotides in thermal assays, correcting previous methodological interpretations.
4. Physiological Context: By integrating binding data with actual intracellular metabolite concentrations, the paper demonstrates that TRPM2 activation relies on the saturation of the MHR1/2 site, with the channel requiring cooperative binding events (Hill coefficient ~5.5) to open, rather than sequential occupation of both sites.

Conclusion

This paper resolves long-standing ambiguities in TRPM2 regulation by demonstrating that the MHR1/2 domain is the primary physiological sensor for ADPR. The NUDT9H domain, while structurally integrated and necessary for channel stability, does not function as a high-affinity ligand-binding site for gating under normal cellular conditions. These findings provide a critical foundation for designing specific TRPM2 modulators targeting the MHR1/2 pocket for therapeutic intervention in oxidative stress-related diseases.